The critical role of the 15-LOX-1 metabolite (13-HODE) in the progression of prostate cancers and the inhibition of 15-LOX-1 activity for apoptosis induction in PC3 cells has been demonstrated. The gene discussed is OLR1; the disease is prostate carcinoma.